Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia (Q43270175)

17 November 2017

Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia (English)

1 reference

17 November 2017

1 reference

Alice Y S Law

1

1 reference

PubMed ID

19786016

17 November 2017

Chris K C Wong

series ordinal

2

1 reference

PubMed ID

19786016

17 November 2017

language of work or name

English

0 references

publication date

26 September 2009

1 reference

Experimental Cell Research

17 November 2017

1 reference

17 November 2017

316

1 reference

17 November 2017

466-476

1 reference

17 November 2017

3

1 reference

Identification of a second stanniocalcin cDNA in mouse and human: stanniocalcin 2.

17 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Molecular cloning and characterization of stanniocalcin-related protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Molecular cloning of a second human stanniocalcin homologue (STC2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Stanniocalcin 2: characterization of the protein and its localization to human pancreatic alpha cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Mammalian stanniocalcins and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Tumor vascular proteins as biomarkers in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Identification of NTN4, TRA1, and STC2 as prognostic markers in breast cancer in a screen for signal sequence encoding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Molecular classification of primary breast tumors possessing distinct prognostic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Co-localization of stanniocalcin-1 ligand and receptor in human breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

ER stress, hypoxia tolerance and tumor progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

"Translating" tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

The role of HIF-1 alpha in transcriptional regulation of the proximal tubular epithelial cell response to hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Integration of oxygen signaling at the consensus HRE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Mammalian gene expression program resiliency: the roles of multiple coactivator mechanisms in hypoxia-responsive transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

The murine stanniocalcin 2 gene is a negative regulator of postnatal growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

XBP1 is essential for survival under hypoxic conditions and is required for tumor growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Tumor dormancy: elevated expression of stanniocalcins in late relapsing breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

Unconventional splicing of XBP-1 mRNA in the unfolded protein response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2009.09.018

10.1016/J.YEXCR.2009.09.018

7 January 2021

Identifiers

DOI

1 reference

17 November 2017

1 reference

PubMed ID

19786016